ClearPoint Neuro, Inc.

NASDAQ:CLPT

Medical - Devices

Healthcare
$7.71 +5.30%

+$0.89 today

Market cap
$247.14M
Beta
1.31
P/E (TTM)
-18.0
EPS (TTM)
-$0.98
52W Low $8.27High $30.10

Volume 0.64M

Average 0.67M

CLPT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

ClearPoint Neuro, Inc.NASDAQ: CLPT

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 62.2%

Gross margin was 62.2% in Q1 FY2026, up 1.8 pp from a year earlier. On a trailing-twelve-month basis it was 61.8%, up 0.6 pp year over year. Over 3 fiscal years it narrowed by 4.5 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
62.2%+0.7 pp QoQ
Last fiscal yearDec 2025
61.4%+0.5 pp YoY
LTMMar 2026
61.8%+0.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.8 pp——
1 year+0.5 pp——
3 years-4.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
61.4%
Year-over-year change
+0.5pp

Gross Margin vs competitors

How CLPT compares with its peers on the latest reported figures

  • CLPT's LTM Mar 2026 gross margin of 61.8% is the 4th highest of the 9 companies compared; the peer median is 50.1%.
  • Its year-over-year change of +0.6 pp is the 3rd highest of 9, against a peer median of +0.1 pp.
  • Over three fiscal years its change of -4.5 pp compares with a peer median of -5.9 pp.
CLPT Competitors Peer median
Gross Margin for CLPT and competitors
Company Period LTM level YoY 3-year change
AKBAAkebia Therapeutics, Inc.LTM Mar 202680.9% +8.2 pp-9.0 pp
SIBNSI-BONE, Inc.LTM Mar 202679.6% +0.3 pp-5.7 pp
OFIXOrthofix Medical Inc.LTM Mar 202669.0% +1.9 pp-6.1 pp
CLPTClearPoint Neuro, Inc.LTM Mar 202661.8% +0.6 pp-4.5 pp
CTKBCytek Biosciences, Inc.LTM Mar 202651.7% -3.2 pp-9.7 pp
AVNSAvanos Medical, Inc.LTM Mar 202648.6% -6.2 pp-7.9 pp
LABStandard BioTools Inc.LTM Mar 202648.3% -1.2 pp+12.0 pp
VREXVarex Imaging CorporationLTM Apr 202633.6% -0.2 pp+1.4 pp
SNDLSNDL Inc.LTM Mar 202627.2% +0.6 pp+7.6 pp
CMPSCOMPASS Pathways plcFY2025— ——
Peer median (excluding CLPT) 50.1%+0.1 pp-5.9 pp

Competitors are the stored peer set for CLPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue16.3M20.55M23.96M31.39M36.97M
Cost of Revenue5.18M7.02M10.34M12.27M14.28M
Gross Profit11.12M13.53M13.61M19.12M22.69M
Gross Margin68.2%65.8%56.8%60.9%61.4%
Research & Development9.28M10.89M11.71M12.39M13.9M
Selling, General & Admin15.22M18.97M24.35M26.48M32.96M
Operating Expenses24.5M29.86M36.06M38.87M46.86M
Depreciation & Amortization692K777K1.46M1.9M2.24M
EBITDA(12.75M)(15.58M)(20.63M)(17.01M)(20.86M)
EBITDA Margin-78.2%-75.8%-86.1%-54.2%-56.4%
Operating Income(13.37M)(16.33M)(22.45M)(19.75M)(24.16M)
Operating Margin-82.1%-79.5%-93.7%-62.9%-65.4%
Interest Income00386K872K1.21M
Interest Expense973K81K002.39M
Other Income / Expenses(1.04M)(103K)357K832K(1.32M)
Income Before Tax(14.41M)(16.44M)(22.09M)(18.91M)(25.49M)
Pre-Tax Margin-88.4%-80.0%-92.2%-60.3%-68.9%
Income Tax Expense000055K
Net Income(14.41M)(16.44M)(22.09M)(18.91M)(25.54M)
Net Margin-88.4%-80.0%-92.2%-60.3%-69.1%
EPS (Basic)(0.69)(0.68)(0.90)(0.70)(0.90)
EPS (Diluted)(0.69)(0.68)(0.90)(0.70)(0.90)
Weighted Avg Shares20.73M24.18M24.61M27.03M28.32M
Weighted Avg Shares (Diluted)20.73M24.18M24.61M27.03M28.32M

ClearPoint Neuro, Inc.

NASDAQ:CLPT

Intrinsic Alpha fair value

Locked

Current Price

$7.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.